12:00 AM
 | 
Mar 09, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

geneX regulatory update

China's State Food and Drug Administration (SFDA) approved Biocomposites' geneX as a bone graft substitute. The...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >